Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Epidemiology Study in Major Orthopaedic Surgery

20 juillet 2006 mis à jour par: Hoersholm Hospital

The purpose of this study is to:

  • Create a database including a description of the patient population that undergoes total hip replacement with special emphasis on orthopedic and cardiovascular complications and the quality of life 1 year postoperatively.
  • Characterise the patient at risk for the above mentioned events
  • Create methods for predicting patients at risk for short-term (90 days) and long term (1 year) complications in relation to hip replacement surgery.

Aperçu de l'étude

Statut

Complété

Description détaillée

Introduction:

Total hip replacement surgery is a standard procedure, which has been shown to be both cost-effective and to give the patient a pain free daily living. Since Sir Charnley made total hip replacement a standard procedure millions of hips have been implanted.

In Denmark about 100 out of 100.000 did get a hip replacement operation in 2001(DHAR).

When a patient with a painful hip due to arthrosis, arthritis, fracture sequelae and other reasons, is offered a total hip replacement, several issues are taken into consideration: concurrent diseases, bone quality, age, life expectancy, prosthesis type, operation methods etc.

In the elderly patient a thorough medical evaluation is performed in order to minimise the intraoperative risc for cardiopulmonary morbidity. Nearly all patients in Denmark (over 99%) are getting thromboprophylaxis during the hospital stay to minimise cardiovascular complications.

After surgery the patients visits the outpatient clinic for routine control after 3 and 12 months. After that time the patient is usually out of orthopedic control.

Evaluations of the procedures in Scandinavian countries are collected in databases. These databases are constructed by national collection of data sheets from each hospital performing the procedures. The collected data most often only include data as far as the arthroplasty is concerned. Normally there is no monitoring of the quality of the collected data - a considerable margin of errors in the results produced from these databases must there for be expected.

The amount of publications concerning total joint replacement is enormous, but most publications in this field come from clinical trials dealing with new pharmacological products or new implants.

Very few authors have considered the overall patient morbidity and quality of life after the hip replacement operation.

Therefore this Ph.D. project is planned to get more and newer data of the population that is offered a total hip replacement. Furthermore, it will be attempted to find prognostic factors as far as the overall risk for cardiopulmonary complications in the first 1 - 3 years after the operation.

Purpose:

The purpose of this study is to:

Create a database including a description of the patient population that undergo total hip replacement with special emphasis on orthopedic and cardiovascular complications and the quality of life 1 year postoperatively.

Characterise the patient at risk for the above mentioned events

Create methods for predicting patients at risk for short-term (90 days) and long term (1 years) complications in relation to hip replacement surgery.

Hypothesis:

It is a well defined small group of high risk patients that gets the serious cardiovascular complications.

The risk for cardiovascular complications is increased for a longer period than the postoperative hospital stay.

A not neglectable group of the patients do not get the expected benefit from the operation.

Methods:

A prospective monocentre, longitudinal cohort study of 500 patients operated in the County of Frederiksborg from 01.01 2004.

The data will be collected by interview before the operation, on day 5 and after 3 month and a year.

And additional data will be collected from patient files, local hip- and anaesthesia databases, laboratory system, the Danish Hospital Discharge Register (LPR), autopsy reports and death register.

Statistical methods:

In the PhD study is included various courses, including a course on statistical methods. External statistical aid might be necessary.

Patients:

Inclusion criteria:

All patients to be operated with total hip replacement in Frederiksborg amt from 01.01.2004 until 500 pt. have been included.

Exclusion criteria:

Refuse of consent and age under 18years.

Ethical Considerations:

Local Scientific Ethical Committee and theDanish Dataprotection Agency has to approve the project.

The project follows the Guidelines for Good Clinical Practise.

The investigation will not imply any discomfort and no risk for the patient.

Type d'étude

Observationnel

Inscription

500

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Hoersholm, Danemark, 2970
        • Hoersholm Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • All patients operated with Hip Arthroplasty Replacement in Hillerød and Hørsholm Hospitals from 1.1 2004.

Exclusion Criteria:

  • Written informed consent denied
  • Patients under 18 years of age.
  • Patients not habitants of Denmark at the time of the operation.
  • Patients without a CPR-number (civil registration number).

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Les enquêteurs

  • Chaise d'étude: Camilla Ryge, MD, Hoersholm Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 janvier 2004

Achèvement de l'étude

1 mai 2006

Dates d'inscription aux études

Première soumission

9 septembre 2005

Première soumission répondant aux critères de contrôle qualité

9 septembre 2005

Première publication (Estimation)

12 septembre 2005

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

21 juillet 2006

Dernière mise à jour soumise répondant aux critères de contrôle qualité

20 juillet 2006

Dernière vérification

1 septembre 2005

Plus d'information

Termes liés à cette étude

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Qualité de vie

3
S'abonner